{
  "ticker": "JNJ",
  "target_date": "2025-01-13",
  "actual_date": "2025-01-13",
  "collected_at": "2025-12-08T11:16:05.941266",
  "price": {
    "open": 138.73,
    "high": 140.76,
    "low": 138.08,
    "close": 140.1790313720703,
    "volume": 10376400,
    "change_1d_pct": 1.7,
    "change_7d_pct": -0.1,
    "change_30d_pct": -6.5
  },
  "technicals": {
    "rsi_14": 52.7,
    "sma_20": 140.33,
    "sma_50": 145.49,
    "macd": -1.848,
    "macd_signal": -2.095,
    "macd_histogram": 0.247,
    "bb_upper": 142.86,
    "bb_lower": 137.8,
    "price_vs_sma20_pct": -0.11,
    "price_vs_sma50_pct": -3.65,
    "volume_ratio": 1.27
  },
  "fundamentals": {
    "market_cap": 488870084608,
    "pe_ratio": 19.585909,
    "forward_pe": 19.142452,
    "price_to_book": 6.1586795,
    "price_to_sales": 5.3052135,
    "profit_margin": 27.26,
    "operating_margin": 30.2,
    "roe": 33.62,
    "roa": 8.26,
    "revenue_growth": 6.8,
    "earnings_growth": 91.0,
    "debt_to_equity": 57.766,
    "current_ratio": 1.074,
    "quick_ratio": 0.711,
    "dividend_yield": 258.0,
    "fifty_two_week_high": 207.81,
    "fifty_two_week_low": 140.68,
    "fifty_day_avg": 193.4922,
    "two_hundred_day_avg": 170.2741,
    "analyst_target": 203.41833,
    "analyst_recommendation": "buy",
    "num_analysts": 24,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -2.36,
    "pct_from_52w_low": 44.24
  },
  "macro": {
    "spy": {
      "price": 576.34,
      "change_1d_pct": 0.16,
      "change_7d_pct": -0.56
    },
    "vix": {
      "level": 19.19,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.8
    },
    "dollar_index": {
      "level": 109.96
    },
    "gold": {
      "price": 2673.5
    },
    "regime": "BEAR_NORMAL"
  },
  "news": [
    {
      "headline": "Top 5 Cancer Pharma Stocks With Strong Risk/Reward In 2025",
      "source": "SeekingAlpha",
      "datetime": 1736791802,
      "summary": "The cancer therapeutics market is set to exceed $400 billion. Read why five pharmaceutical companies offer attractive opportunities for investors.",
      "url": "https://finnhub.io/api/news?id=5893587e5fa3e91a37b6975c5ceac34f7fc311555b4dc90278e6109cce22d835"
    },
    {
      "headline": "Johnson & Johnson (JNJ) 43rd Annual J.P. Morgan Healthcare Conference (Transcript)",
      "source": "SeekingAlpha",
      "datetime": 1736785632,
      "summary": "Johnson &amp; Johnson (NYSE:JNJ) 43rd Annual J.P. Morgan Healthcare Conference January 13, 2024 12:00 PM ETCompany ParticipantsJoaquin Duato - Chairman...",
      "url": "https://finnhub.io/api/news?id=e56fd61be06abff9e44cbeb078f21a63b2823a6377cba48aa1391c2c66258da9"
    },
    {
      "headline": "J&J Announces A Splashy $14.6 Billion Deal, While Lilly Tacks On A Cancer Drug",
      "source": "DowJones",
      "datetime": 1736785195,
      "summary": "J&J Announces A Splashy $14.6 Billion Deal, While Lilly Tacks On A Cancer Drug",
      "url": "https://finnhub.io/api/news?id=94ff49b9c5e3791c67b83932bf73a23a079ab25c2774a335016598fc741d645c"
    },
    {
      "headline": "Johnson & Johnson to Acquire Intra-Cellular in $15 Billion Deal",
      "source": "DowJones",
      "datetime": 1736781180,
      "summary": "Johnson & Johnson to Acquire Intra-Cellular in $15 Billion Deal",
      "url": "https://finnhub.io/api/news?id=ffae4d9add57f6212f7069c3724594f018ff3038994a55b18b8d643e344247a8"
    },
    {
      "headline": "UnitedHealth, Caterpillar share gains contribute to Dow's 240-point climb",
      "source": "MarketWatch",
      "datetime": 1736773140,
      "summary": "UnitedHealth, Caterpillar share gains contribute to Dow's 240-point climb",
      "url": "https://finnhub.io/api/news?id=acefd6c62b5e03c69f1a52f64769dcd68743f1fbdf4f7407acb14bb7b9c5ad1f"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2024-12-12",
      "description": "xslF345X05/wk-form4_1734042449.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000106/xslF345X05/wk-form4_1734042449.xml"
    },
    {
      "form": "4",
      "date": "2024-12-12",
      "description": "xslF345X05/wk-form4_1734041779.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000104/xslF345X05/wk-form4_1734041779.xml"
    },
    {
      "form": "4",
      "date": "2024-12-12",
      "description": "xslF345X05/wk-form4_1734041373.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000102/xslF345X05/wk-form4_1734041373.xml"
    },
    {
      "form": "13F-HR",
      "date": "2024-11-13",
      "description": "xslForm13F_X02/primary_doc.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000090445424000604/xslForm13F_X02/primary_doc.xml"
    },
    {
      "form": "10-Q",
      "date": "2024-10-23",
      "description": "jnj-20240929.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000096/jnj-20240929.htm"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}